What can we help you find?

Leading the way in transplantation

Filter results for:

ITS Meeting 2022 – Thank you & Register now

We would like to extend a sincere thank you to everyone who submitted an abstract for ITS Meeting 2022 jointly organised with the American Society of Transplantation (AST) and The Transplantation Society (TTS). It is very encouraging to see the level of abstracts being put forward for this edition! Corresponding authors will be notified of

ITS Meeting 2022 – Venue & Hotel Accommodation

Venue & Hotel Accommodation You can now book your hotel accommodation for ITS Meeting 2022! Here some useful information:   Hotel Titanic Chausse Berlin Chausseestraße 30 10115 Berlin, Germany   Website: www.titanic.com.tr/titanic-chaussee-berlin Tel: +49 303116858880 Email: reservations.tcb@titanic-hotels.de   The hotel staff will ensure you are offered the best rate available at the time of reservation.

WEBINAR: What you need to know about vaccinating your kidney transplanted patients against COVID-19

This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the pro´s and con´s for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations – and gives

BSC Call for Nominations

We would like to announce a call for nominations for two new Board members. All ESOT/Basic Science Committee affiliates are eligible to submit their application for the positions. Applications from PhDs with some years of postdoc experience and researchers with a strong basic science background will be given preferential consideration. The Board reserves the right

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader